Showing results (51-60 of 151) with videos related to
Sort By:
Pageof 16
American Journal of Medical Genetics. Part A|December 17, 2009
Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndromeElaine Tierney, Sandra K Conley, Halima Goodwin, et al.Journal of Neuro-Oncology|September 1, 1989
Toxicity of IL-2 and Corynebacterium parvum following direct intracranial injectionR C Sutton, J Kennedy, J Duncan, et al.International Immunology|March 1, 1995
Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1B Engelhardt, F K Conley, P J Kilshaw, et al.The Journal of Cell Biology|January 1, 1991
Sequence of the clathrin heavy chain from Saccharomyces cerevisiae and requirement of the COOH terminus for clathrin functionS K Lemmon, A Pellicena-Palle, K Conley, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDST L Vollmer, M K Waldor, L Steinman, et al.Pituitary|November 18, 2000
The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormoneL K Conley, R S Brogan, A Giustina, et al.The Hospice Journal|March 29, 2001
Intermittent subcutaneous injections for symptom control in hospice care: a retrospective investigationM Letizia, J Shenk, T D JonesAmerican Journal of Medical Genetics. Part A|July 17, 2010
Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndromeGrace Koo, Sandra K Conley, Christopher A Wassif, et al.The American Journal of Hospice & Palliative Care|February 8, 2000
Intermittent subcutaneous injections of pain medication: effectiveness, manageability, and satisfactionM Letizia, J Shenk, T D JonesPageof 16